Skip to Content
Merck
  • Modeling Hypoxia-Induced Neuropathies Using a Fast and Scalable Human Motor Neuron Differentiation System.

Modeling Hypoxia-Induced Neuropathies Using a Fast and Scalable Human Motor Neuron Differentiation System.

Stem cell reports (2020-05-11)
Laura I Hudish, Andrew Bubak, Taylor M Triolo, Christy S Niemeyer, David S Lorberbaum, Lori Sussel, Maria Nagel, J Matthew Taliaferro, Holger A Russ
ABSTRACT

Human motor neuron (MN) diseases encompass a spectrum of disorders. A critical barrier to dissecting disease mechanisms is the lack of appropriate human MN models. Here, we describe a scalable, suspension-based differentiation system to generate functional human MN diseases in 3 weeks. Using this model, we translated recent findings that mRNA mis-localization plays a role in disease development to the human context by establishing a membrane-based system that allows efficient fractionation of MN cell soma and neurites. In response to hypoxia, used to mimic diabetic neuropathies, MNs upregulated mitochondrial transcripts in neurites; however, mitochondria were decreased. These data suggest that hypoxia may disrupt translation of mitochondrial mRNA, potentially leading to neurite damage and development of neuropathies. We report the development of a novel human MN model system to investigate mechanisms of disease affecting soma and/or neurites that facilitates the rapid generation and testing of patient-specific MN diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-ISL-1 Antibody, from rabbit, purified by affinity chromatography